This week we are pleased to be joined by our friend Joe McCann, founder of Slingshot Insights. In this episode, Leigh and Joe weigh in on the current debate over inflated drug pricing (starts at 3:23), discuss updates to the Martin Shkreli story, the disgraced CEO of Turig Pharmaceuticals that kicked off this whole controversy (16:45), and we get Joe’s picks for biotech stocks to watch in 2016 (10:50).
Related Posts
Visualizing Textbook And Alternative Interpretations Of The Friedman Analysis Of The Sanders Economic Plan
If China Held A Normal Amount Of Reserves, Would Its Currency Be Higher Or Lower Against The Dollar?
The Imminent Multi-Trillion Dollar Surge In Social Security & Medicare Costs
May 2017 Producer Price Final Demand Year-Over-Year Inflation Moderates To 2.4%
Low Volume Flag Breakout! What’s Next For S&P 500?
Look Out: Euro Jumps As Draghi Silent On FX Risk, PMIs Come In Hot
Leave A Comment